AINMF.US NetraMark Holdings Inc.

Healthcare Health Care Technology USA Stocks
0.4317 USD
Close of Nov 13, 2026
0.3444 0.8922
Market cap
USD 40.9M
P/E
-
P/B
19.42x
ROE
-221.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is AINMF.US undervalued?

Graham number

The Graham number of NetraMark Holdings Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NetraMark Holdings Inc. fundamental analysis

No fundamental analysis for NetraMark Holdings Inc. yet.

NetraMark Holdings Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NetraMark Holdings Inc.

NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc…

Full company profile